Gene: KRT17
Official Full Name: keratin 17provided by HGNC
Gene Summary: This gene encodes the type I intermediate filament chain keratin 17, expressed in nail bed, hair follicle, sebaceous glands, and other epidermal appendages. Mutations in this gene lead to Jackson-Lawler type pachyonychia congenita and steatocystoma multiplex. [provided by RefSeq, Aug 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO36874 | KRT17 Knockout cell line (HeLa) | Human | KRT17 | 1:3~1:6 | Negative | Online Inquiry |
KO36875 | KRT17 Knockout cell line (HEK293) | Human | KRT17 | 1:3~1:6 | Negative | Online Inquiry |
KO36876 | KRT17 Knockout cell line (A549) | Human | KRT17 | 1:3~1:4 | Negative | Online Inquiry |
KRT17 Gene Knockout Cell Lines represent a critical innovation in the field of molecular biology and genetics. These cell lines are engineered to disrupt the expression of the KRT17 gene, which encodes keratin 17, a protein implicated in various cellular processes, including keratinocyte differentiation, epithelial integrity, and response to stress. The knockout of this gene allows researchers to investigate its role in skin pathologies, cancer, and other diseases, providing a powerful tool for understanding the mechanistic underpinnings of these conditions.
The primary mechanism of action involves CRISPR/Cas9 technology, which facilitates precise editing of the target gene, ensuring that the KRT17 expression is effectively silenced. This genetic disruption not only allows for the study of KRT17’s individual contributions but also aids in comprehensively understanding its interaction with other signaling pathways within the cell. As such, these cell lines can simulate disease states or cellular responses under controlled laboratory conditions, thereby furnishing insight into therapeutic targets.
The scientific significance of KRT17 Gene Knockout Cell Lines extends to clinical research, particularly in oncology and dermatology, where keratin 17 has been linked to tumor development and skin disorders. By enabling a focused investigation on KRT17's functional implications, researchers can directly advance the development of novel treatment strategies and diagnostics.
Compared to alternative cell lines or knockout methods, our KRT17 Gene Knockout Cell Lines boast enhanced specificity and efficiency due to the high fidelity of the CRISPR/Cas9 system utilized in their creation. Additionally, they are provided with robust characterization data, ensuring researchers have the confidence that the cell lines will yield reproducible results in their experiments.
The value of KRT17 Gene Knockout Cell Lines to researchers and clinicians lies in their ability to uncover new insights into disease mechanisms and the potential to inform therapeutic interventions. They serve as an indispensable asset for any laboratory focused on exploring the intricate roles of keratin proteins in human health and disease.
Our company prides itself on being at the forefront of genetic engineering and cellular biology, delivering high-quality biological products that cater to the evolving needs of the research community. With our commitment to scientific excellence and customer support, we empower researchers to make transformative discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.